Company Filing History:
Years Active: 2006-2007
Title: The Innovative Journey of John Smoliga
Introduction
John Smoliga is a notable inventor based in Brookfield, CT (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on the development of crystalline forms and polymorphs of various compounds, showcasing his expertise in chemical innovation.
Latest Patents
Among his latest patents are the crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2',3′-e] [1,4]diazepin-6-one, which includes both dihydrate and anhydrous forms. Additionally, he has developed polymorphs of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea, along with processes for their production.
Career Highlights
John Smoliga has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.
Collaborations
Throughout his career, John has collaborated with talented individuals such as Jana Vitous and Carl Alan Busacca. These partnerships have fostered a creative environment that has led to innovative solutions in his field.
Conclusion
John Smoliga's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new and effective pharmaceutical compounds.